Neoadjuvant CAPOX Plus Tislelizumab vs CAPOX in MSS High-Risk Locally Advanced Colon Cancer

Clinical trial NCT07132008 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07132008
Sponsor: First Affiliated Hospital of Guangxi Medical University
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Colonic Neoplasms Neoadjuvant Therapy Immune Checkpoint Inhibitors

Start date: 2025-10-01
Primary completion: 2027-09-30
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.